Literature DB >> 40797

Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade.

T J Maling, A Ferrara, J C Mucklow, J L Reid, C A Hamilton, C T Dollery.   

Abstract

The acute effects upon blood pressure and sympathetic outflow of two beta adrenoceptor blocking drugs, propranolol and atenolol, are described in five healthy normotensive subjects. Supine blood pressure, heart rate, plasma noradrenaline, and urinary catecholamine excretion were measured before and at intervals for 24 h after a single oral dose of either propranolol 200 mg, atenolol 100 mg, or placebo. Propranolol caused a fall in blood pressure and heart rate of 17.2/14.1 mm Hg and 20.4 beats/min respectively two hours after dose. Atenolol caused a fall in blood pressure of 11.4/18.6 mm Hg within 7 h of the dose, and a fall in heart rate of 13.8 beats/min after 2 h. The reduction in blood pressure after single high dose beta adrenoceptor blockade is established. The synchronous reduction in blood pressure and heart rate after propranolol was not associated with an increase in peripheral sympathietic activity as assessed by the biochemical indices. It is conceivable that the reduction in blood pressure during beta adrenoceptor blockade may be due in part to inappropriately low sympathetic activity but this cannot be the main mechanism of pressure reduction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40797     DOI: 10.1007/bf00561734

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  HYPOTENSIVE ACTION OF PRONETHALOL.

Authors:  B N PRICHARD
Journal:  Br Med J       Date:  1964-05-09

3.  Improved technique for the fluorimetric estimation of catecholamines.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1961-04

4.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

5.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man.

Authors:  A M Michelakis; R G McAllister
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

6.  -Adrenergic receptors in the central nervous system of the cat concerned with control of arterial blood pressure and heart rate.

Authors:  M D Day; A G Roach
Journal:  Nat New Biol       Date:  1973-03-07

7.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

8.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

9.  The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients.

Authors:  B Hökfelt; H Hedeland; B G Hansson
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-02

10.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
View more
  2 in total

1.  Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy.

Authors:  F H Leenen; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.

Authors:  P C O'Connor; M J Finch; D W Harron; P A Meredith; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.